RxDoctor Payments Data

Kevin Audlin, MD

Gynecologic Oncology · Towson, MDNPI 1841247483

Payments from drug & device makers

What this record shows

This record is dominated by education: $103,430 of the $165,759 with a category attached, or 62.4%. Olympus Corporation Of The Americas accounts for 64.2% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $94,591 and has fallen 87.3% since, to $12,007 in 2025. Among gynecologic oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$165,759in general payments, 2019–2025

Across 378 payments — averaging $438.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$106K
  • AbbVie$36K
  • Intuitive Surgical$14K
  • Conmed Corporation$6K
  • Johnson & Johnson$565
  • Olympus America Inc.$456
  • plus $2K from 22 others

What the payments were for

  • Consulting fees$2,2501%
  • Speaking & faculty fees$39,02524%
  • Travel & lodging$11,7367%
  • Food & beverage$9,3196%
  • Education$103,43062%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$165,759 in reported general payments places this provider in the 95th percentile of 35 gynecologic oncology providers in Maryland.

See all gynecologic oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$57,208
Medicare patients
150
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tolterodine Tartrate ErTolterodine Tartrate15$1,504
Tolterodine Tartrate11$738
Estradiol17$579
Fluconazole15$110
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$49

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →